TITLE

ENZO BIOCHEM GETS NEW PATENT ALLOWANCES IN U.S/CANADA

PUB. DATE
September 2000
SOURCE
Worldwide Biotech;Sep2000, Vol. 12. Issue 9, p1
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Reports the patent application allowances received by Enzo BioChem Inc. in the United States and Canada.
ACCESSION #
3533625

 

Related Articles

  • Patent watch.  // Diagnostics & Imaging Week;9/13/2007, Vol. 10 Issue 37, p6 

    The article reports on the decision of Enzo Biochem to file an appeal of a summary judgment motion, in favor of Applera, by the U.S. District Court, District of Connecticut. The company seeks recovery from defendants for past infringement of what it calls three pioneering patents, all of which...

  • QUESTIONING THE REQUIREMENT FOR WRITTEN DESCRIPTION: ENZO BIOCHEM V. GEN-PROBE AND OVERLY BROAD PATENT CASES. Davis, Paula K. // Indiana Law Review;2004, Vol. 37 Issue 2, p467 

    Discusses cases in the U.S. dealing with written description law, particularly with respect to biotechnology and the associated rise of discord among judges in the U.S. Court of Appeals for the Federal Circuit. Introduction to biotechnology and biotech patents; Development of the written...

  • Federal Circuit Restates Law of Written Description for Biotech Patents.  // Venulex Legal Summaries;2002 Q3, p1 

    The article focuses on the decision of the U.S. Court of Appeals for the Federal Circuit to restate the law of written description for biotechnology patents in the case of Enzo Biochem Inc. and Gen-Probe Inc. Enzo sued the defendants for infringing its patent directed to nucleic acid probes that...

  • U.S. Supreme Court Declines Life Technologies Appeal Hearing in Patent Infringement Suit Brought by Enzo Biochem Claiming Substantial Damages.  // Biomedical Market Newsletter;6/30/2011, p544 

    The article reports on the move of the U.S. Supreme Court to refuse to hear an appeal made by Life Technologies Corp. for the patent infringement suit brought by Enzo Biochem. It mentions that the decision has paved the way for Enzo to pursue its claim for substantial damages against Life...

  • Jury awards Enzo $48.6M for patent infringement.  // Medical Device Daily;11/5/2012, Vol. 16 Issue 214, p4 

    This article reports on the victory of Enzo Biochem in a patent infringement trial against Applera, now Life Technologies.

  • Patent Watch.  // Nature Reviews Drug Discovery;Sep2002, Vol. 1 Issue 9, p662 

    Reports on news and developments concerning drug patents worldwide, as of September 2002. Ruling by the British Court of Appeal in July 2002 frees Transkarytotic Therapeutics (TKT) and Aventis to market erythropoietin in Great Britain; Enzo Biochem's patent for bacterial probes; ARIAD...

  • Spontaneous Mutation: A Sudden Change in the Evolution of the Written Description Requirement as It Applies to Genetic Patents. Linstrom, Duane M. // San Diego Law Review;Summer2003, Vol. 40 Issue 3, p947 

    Examines the history of the ways in which courts have applied the written description requirement to gene patents with a particular focus on the changes in the law wrought by the decision on the case Enzo Biochem Inc. versus Gen-Probe Inc. Details of the written description requirement;...

  • Enzo Biochem files appeal after judge rules in favor of Applera.  // Medical Device Daily;9/10/2007, Vol. 11 Issue 172, p2 

    The article reports on the appeal filed by Enzo Biochem in line with the summary judgment issued by the U.S. District Court in the District of Connecticut which favored Applera et al. The appeal seeks to reverse the ruling in the patent infringement suit filed by Enzo against the defendants....

  • Enzo Biochem awarded DNA patent.  // Long Island Business News (7/1993 to 5/2009);8/8/94, Vol. 41 Issue 32, p34 

    Reports that the US Patent Office issued Enzo Biochem Inc. a patent incorporating the labeling of DNA molecule. Impact of DNA labeling on developments in medicine; Previous patents received by Enzo.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics